UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (18) 18
humans (14) 14
life sciences & biomedicine (14) 14
animals (10) 10
potent (9) 9
cancer (7) 7
pharmacology & pharmacy (6) 6
physical sciences (6) 6
antineoplastic agents - therapeutic use (5) 5
chemistry (5) 5
oncology (5) 5
antineoplastic agents - pharmacology (4) 4
cell line, tumor (4) 4
clinical trials as topic (4) 4
drug delivery (4) 4
drugs (4) 4
female (4) 4
potent antitumor-activity (4) 4
tumors (4) 4
apoptosis (3) 3
biological and medical sciences (3) 3
chemistry, medicinal (3) 3
chemistry, multidisciplinary (3) 3
clinical trials (3) 3
cytotoxicity (3) 3
drug delivery systems (3) 3
mice (3) 3
neoplasms - drug therapy (3) 3
potent anticancer activity (3) 3
proteins (3) 3
structure-activity relationship (3) 3
therapy (3) 3
activation (2) 2
analogs (2) 2
antitumor (2) 2
binding sites (2) 2
biochemistry & molecular biology (2) 2
biotechnology (2) 2
cancer therapies (2) 2
care and treatment (2) 2
chemotherapy (2) 2
colonic neoplasms - metabolism (2) 2
combination (2) 2
cyclin-dependent kinases - antagonists & inhibitors (2) 2
cyclin-dependent kinases - metabolism (2) 2
cytotoxic (2) 2
doxorubicin - analogs & derivatives (2) 2
drug delivery systems - methods (2) 2
drug design (2) 2
drug development (2) 2
drug discovery (2) 2
genetic therapy (2) 2
growth-factor receptor (2) 2
immunology (2) 2
in-vitro (2) 2
in-vivo (2) 2
life sciences (2) 2
materials science (2) 2
medical sciences (2) 2
molecular targeted therapy (2) 2
mutation (2) 2
necrosis-factor-alpha (2) 2
neoplasm staging (2) 2
neoplasms - pathology (2) 2
novel (2) 2
peptides (2) 2
pharmacokinetics (2) 2
pharmacology. drug treatments (2) 2
potent cytotoxicity (2) 2
protein kinase inhibitors - pharmacology (2) 2
review (2) 2
rna, small interfering - metabolism (2) 2
science & technology - other topics (2) 2
side effects (2) 2
signal transduction - drug effects (2) 2
synthesis (2) 2
technology (2) 2
tumor necrosis factor-alpha - metabolism (2) 2
umcg approved (2) 2
valproic acid (2) 2
vehicles (2) 2
2-pyrollinodoxorubicin (1) 1
3-kinase/akt signaling pathway (1) 1
[info.info-bt]computer science [cs]/biotechnology (1) 1
[sdv.imm.imm] life sciences [q-bio]/immunology/immunotherapy (1) 1
[sdv.imm]life sciences [q-bio]/immunology (1) 1
[sdv] life sciences [q-bio] (1) 1
acetyltransferases - antagonists & inhibitors (1) 1
acetyltransferases - genetics (1) 1
acetyltransferases - metabolism (1) 1
acids (1) 1
acquired-resistance (1) 1
activity (1) 1
acute myeloid-leukemia (1) 1
administration, oral (1) 1
adult (1) 1
advanced solid tumors (1) 1
aged (1) 1
agents (1) 1
albumin-based nanoparticle paclitaxel-snapist trials (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Drug resistance updates, ISSN 1368-7646, 2005, Volume 8, Issue 6, pp. 381 - 402
Therapeutic proteins | Angiogenesis | Gene delivery | Arg-Gly-Asp | Drug delivery | Antivascular therapies | Polymers | Radiotracer | RGD | Endothelial cells | Cytostatic drugs | Cancer | endothelial cells | VITRONECTIN RECEPTOR ANTAGONIST | SNAKE-VENOM DISINTEGRINS | angiogenesis | NECROSIS-FACTOR-ALPHA | drug delivery | UMCG Approved | therapeutic proteins | CANCER ALPHA(V)-INTEGRIN EXPRESSION | gene delivery | POTENT ANTITUMOR-ACTIVITY | CONDITIONALLY REPLICATIVE ADENOVIRUSES | POSITRON-EMISSION-TOMOGRAPHY | radiotracer | cytostatic drugs | ALPHA(V)BETA INTEGRIN ANTAGONISTS | VIRUS-LIKE PARTICLES | cancer | antivascular therapies | polymers | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Neoplasms - metabolism | Recombinant Proteins - therapeutic use | Tumor Necrosis Factor-alpha - metabolism | Doxorubicin - therapeutic use | Genetic Therapy | RNA, Small Interfering - genetics | Humans | Tumor Necrosis Factor-alpha - genetics | Antineoplastic Agents - therapeutic use | Neoplasms - diagnosis | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - genetics | Drug Carriers - chemistry | Integrin alphaVbeta3 - metabolism | Peptides, Cyclic - metabolism | Oligopeptides - therapeutic use | Antineoplastic Agents - metabolism | Transfection | Neoplasms - genetics | Doxorubicin - analogs & derivatives | Doxorubicin - metabolism | Oligopeptides - chemistry | Polyethylene Glycols - metabolism | Recombinant Proteins - metabolism | Endothelial Cells - metabolism | Oligopeptides - genetics | Genetic Vectors - metabolism | Clinical Trials as Topic | Oligopeptides - metabolism | Genetic Vectors - genetics | Neoplasms - drug therapy | Integrin alphaVbeta3 - analysis | Tumor Necrosis Factor-alpha - therapeutic use | Animals | Mutation | RNA, Small Interfering - metabolism | Proteins | Drugs | Drug delivery systems | Care and treatment | Peptides | Radioactive tracers | Health aspects | Tumors | Vehicles | Index Medicus
Journal Article
Journal Article
Heterocycles, ISSN 0385-5414, 12/2000, Volume 53, Issue 12, pp. 2719 - 2737
Journal Article
Journal Article